Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids

Comparative Medicine

Volumn 57, Issue 4, 2007, Pages 377-382

  Dauchy, Robert T ^a   Dauchy, Erin M ^a   Davidson, Leslie K ^a   Krause, Jean A ^a   Lynch, Darin T ^a   Tirrell, Paul C ^a   Tirrell, Robert P ^a   Sauer, Leonard A ^a   Van Der Riet, Peter ^a   Blask, David E ^a  

^a BASSETT RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; CONJUGATED LINOLEIC ACID; CORIOLIC ACID; CYCLIC AMP; FORSKOLIN; ICOSAPENTAENOIC ACID; MELATONIN; MELATONIN RECEPTOR; MELATONIN RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGENIC AGENT; N [2 (1 NAPHTHYL)ETHYL]CYCLOBUTANECARBOXAMIDE; PERTUSSIS TOXIN; PROTEIN P42; 13-HYDROXY-9,11-OCTADECADIENOIC ACID; ANTINEOPLASTIC AGENT; LINOLEIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FATTY ACID TRANSPORT; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; NONHUMAN; NUDE RAT; RAT; SQUAMOUS CELL CARCINOMA; TISSUE SPECIFICITY; XENOGRAFT; ANIMAL; BUFFALO RAT; COMPARATIVE STUDY; DRUG EFFECT; DRUG SCREENING; METABOLISM; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; EICOSAPENTAENOIC ACID; HUMANS; LINOLEIC ACIDS; LINOLEIC ACIDS, CONJUGATED; MALE; MELATONIN; RATS; RATS, INBRED BUF; RATS, NUDE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 34548828830     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Black IL, Roche HM, Gibney MJ. 2002. Chronic but not acute treatment with conjugated linoleic acid (CLA) isomers (trans-10, cis-12 CLA and cis-9, trans-11 CLA) affects lipid metabolism in Caco-2 cells. J Nutr 132:2167-2173.
2. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, Lynch DT, Rollag MD, Zalatan F. 2005. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 65:11174-11184.
3. Blask DE, Sauer LA, Dauchy RT. 2002. Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2:113-132.
4. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS. 1999. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res 59:4693-4701.
5. Boudreau M, Sohn K, Rhee S, SH L, Hunt J, Hwang D. 2001. Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase independent pathways. Cancer Res 61:1386-1391.
6. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, Ellis C, Elshourbagy NA, Goetz AS, Minnick DT, Murdock PR, Sauls HR, Jr, Shabon U, Spinage LD, Strum JC, Szekeres PG, Tan KB, Way JM, Ignar DM, Wilson S, Muir AI. 2003. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278:11303-11311.
7. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ. 2003. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312-11319.
8. Dauchy EM, Dauchy RT, Davidson LK, Lynch DT, Krause JA, Blue LM, Sauer LA, Blask DE. 2006. Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. J Am Assoc Lab Anim Sci 45(3):38-44.
9. Dauchy RT, Blask DE, Sauer LA. 2000. Preparation of the inguinal fat pad for perfusion in situ in the rat: a surgical technique that preserves continuous blood flow. Contemp Top Lab Anim Sci 39(5):29-33.
10. Dauchy RT, Dauchy EM, Sauer LA, Blask DE, Davidson LK, Krause JA, Lynch DT. 2004. Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid. Cancer Lett 209:7-15.
11. Dauchy RT, Sauer LA. 1986. Preparation of "tissue- isolated" rat tumors for perfusion: a new surgical technique that preserves continuous blood flow. Lab Anim Sci 36:678-681.
12. Fitscher BA, Elsing C, Riedel HD, Gorski J, Stremmel W. 1996. Protein-mediated facilitated uptake processes for fatty acids, bilirubin, and other amphipathic compounds. Proc Soc Exp Biol Med 212:15-23.
13. Gullino PM, Grantham FH, Courtney AH. 1967. Glucose consumption by transplanted tumors in vivo. Cancer Res 27:1031-1040.
14. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. 2005. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem 280:13285-13291.
15. Jemal A, Siegal E, Ward E, Murray T, Xu J, Smigal C, Thun MJ. 2006. Cancer statistics. CA Cancer J Clin 56:106-130.
16. Jung B, Ahmad N. 2006. Melatonin in cancer management: progress and promise. Cancer Res 66:9789-9793.
17. Kin E, Holthuizen P, Park H, Ha Y, Jung K, Park J. 2002. Trans-10 cis-12 conjugated linoleic acid inhibits Caso-2 colon cancer cell growth. Am J Physiol Gastrointest Liver Physiol 283:G357-G367.
18. Kotarsky K, Nilsson NE, Flodgren E, Owman C, Olde B. 2003. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun 301:406-410.
19. National Research Council. 1996. Guide for care and use of laboratory animals. Washington (DC): National Academy Press.
20. Pointe Scientific [Internet]. 2006. Bulletins P803-G7517-01 (glucose) and P803-7596-01 (lactic acid) [cited 12 July 2006]. Available from http://www.pointescientific.com.
21. Rangan SR. 1972. A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29:117-121.
22. Rose DP, Hatala MA, Connolly JM, Rayburn J. 1993. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 53:4686-4690.
23. Sauer LA, Dauchy RT. 1988. Identification of linoleic and arachidonic acids as the factors in hyperlipemic blood that increase [3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res 48:3106-3111.
24. Sauer LA, Dauchy RT. 1992. The effect of omega-6 and omega-3 fatty acids on 3H-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br J Cancer 66:297-303.
25. Sauer LA, Dauchy RT. 1992. Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo. Br J Cancer 66:290-296.
26. Sauer LA, Dauchy RT, Blask DE. 1997. Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. J Nutr 127:1412-1421.
27. Sauer LA, Dauchy RT, Blask DE. 2000. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res 60:5289-5295.
28. Sauer LA, Dauchy RT, Blask DE. 2001. Melatonin inhibits fatty acid transport in inguinal fat pads of hepatoma 7288CTC-bearing and normal Buffalo rats via receptor-mediated signal transduction. Life Sci 68:2835-2844.
29. Sauer LA, Dauchy RT, Blask DE, Armstrong BJ, Scalici S. 1999. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Res 59:4688-4692.
30. Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM. 2005. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr 135:2124-2129.
31. Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM, Welham KJ, Coupland K. 2004. Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. J Nutr 134:1989-1997.
32. Sauer LA, Nagel WO, Dauchy RT, Miceli LA, Austin JE. 1986. Stimulation of tumor growth in adult rats in vivo during an acute fast. Cancer Res 46:3469-3475.
33. Sauer LA, Stayman JW 3rd, Dauchy RT. 1982. Amino acid, glucose, and lactic acid utilization in vivo by rat tumors. Cancer Res 42:4090-4097.
34. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D. 1997. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res 17:969-973.
35. Yonezawa T, Katoh K, Obara Y. 2004. Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem Biophys Res Commun 314:805-809.
36. Zakim D. 1996. Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Med 212:5-14.